Total Payments
$263.54
2024 Payments
$63.07
Companies
7
Transactions
10
Medicare Patients
20,439
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$263.54 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $263.54 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $88.12 | 2 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $58.94 | 1 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $47.96 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $21.83 | 1 | $0 (2024) |
| Biogen, Inc. | $19.07 | 1 | $0 (2021) |
| Boston Scientific Corporation | $14.44 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $13.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63.07 | 3 | Novo Nordisk Inc ($22.05) |
| 2023 | $13.18 | 1 | Merck Sharp & Dohme LLC ($13.18) |
| 2022 | $109.28 | 4 | Novo Nordisk Inc ($66.07) |
| 2021 | $19.07 | 1 | Biogen, Inc. ($19.07) |
| 2019 | $58.94 | 1 | Actelion Pharmaceuticals US, Inc. ($58.94) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Dermatology | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Respiratory | ||||||
| 11/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO, BELSOMRA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Dermatology | ||||||
| 07/06/2022 | Boston Scientific Corporation | Flexiva (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Flexiva_URO | ||||||
| 04/12/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $66.07 | General |
| Category: Diabetes | ||||||
| 02/16/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Dermatology | ||||||
| 11/02/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| 08/21/2019 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $58.94 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 4,785 | 9,794 | $729,342 | $271,511 |
| 2022 | 71 | 5,224 | 9,910 | $781,874 | $285,878 |
| 2021 | 70 | 5,395 | 11,391 | $850,844 | $307,151 |
| 2020 | 59 | 5,035 | 8,147 | $776,128 | $268,503 |
Total Patients
20,439
Total Services
39,242
Medicare Billing
$1.1M
Procedure Codes
263
All Medicare Procedures & Services
263 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 480 | 941 | $138,327 | $52,750 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 489 | $101,223 | $41,993 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 334 | 334 | $64,796 | $41,747 | 64.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 87 | 316 | $40,764 | $14,413 | 35.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $21,253 | $10,150 | 47.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 52 | 52 | $14,976 | $8,282 | 55.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 489 | 973 | $13,622 | $8,160 | 59.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 467 | 756 | $33,264 | $7,820 | 23.5% |
| 77067 | Screening mammography | Office | 2023 | 58 | 58 | $17,100 | $7,354 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 70 | $15,190 | $6,243 | 41.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 30 | 34 | $9,350 | $5,371 | 57.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 392 | 406 | $24,360 | $5,327 | 21.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 40 | 67 | $11,859 | $5,207 | 43.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 67 | 67 | $5,010 | $4,809 | 96.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 233 | 233 | $21,436 | $4,408 | 20.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 192 | 380 | $17,100 | $3,618 | 21.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 136 | 202 | $14,140 | $3,325 | 23.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 58 | 58 | $8,700 | $2,995 | 34.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 55 | $9,955 | $2,754 | 27.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 19 | $7,182 | $2,506 | 34.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,615 | $2,394 | 66.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 233 | 315 | $9,135 | $2,388 | 26.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 33 | 37 | $5,069 | $2,219 | 43.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 24 | 24 | $17,880 | $2,176 | 12.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 35 | $5,145 | $2,055 | 39.9% |
About Dr. Tyler Hanson, M.D
Dr. Tyler Hanson, M.D is a Internal Medicine healthcare provider based in Yankton, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700800885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyler Hanson, M.D has received a total of $263.54 in payments from pharmaceutical and medical device companies, with $63.07 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($263.54).
As a Medicare-enrolled provider, Hanson has provided services to 20,439 Medicare beneficiaries, totaling 39,242 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 263 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Yankton, SD
- Active Since 07/26/2006
- Last Updated 09/02/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700800885
Products in Payments
- Rybelsus (Drug) $88.12
- ILUMYA (Biological) $47.96
- TEZSPIRE (Biological) $21.83
- Flexiva (Device) $14.44
- VERQUVO (Drug) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Yankton
Amanda Sedlacek, Do, DO
Internal Medicine — Payments: $400.92
Internal Medicine $400.92
Clarissa Barnes, M.d, M.D
Internal Medicine — Payments: $372.66
Internal Medicine $372.66
Gregory Erickson, Md, MD
Internal Medicine — Payments: $68.25
Internal Medicine $68.25
Susan Fanta, Md, MD
Internal Medicine — Payments: $58.25
Internal Medicine $58.25
Jay Hubner, Md, MD
Internal Medicine
Internal Medicine
Beth Mikkelsen, Md, MD
Internal Medicine
Internal Medicine